HERE Technologies, Shields and Infosys Demonstrate 3D Network Planning Solution to Slash Costs of 5G Build-out
HERE Technologies, Shields and Infosys today announced that they are collaborating on a powerful and cost-effective way to perform 5G network design and deployment.
The new solution, to be demonstrated at MWC this week, is designed to help enterprises including mobile network operators (MNOs) save both time and money when performing 5G radio frequency planning. The companies estimate that it would enable enterprises to reduce the time to identify real estate acquisition for 5G small cells as well as cut the cost of RF design by more than 40%.
The solution is a unique blend of technologies. It embeds machine learning software and a service delivery framework from Infosys; expertise in RF and C-RAN (cloud radio access network) design from Shields; and large, precise, scalable 3D datasets derived from terrestrial LiDAR and other remote sensed content from HERE.
The expertise of HERE in extracting features and 3D derivative objects such as poles, trees, terrain models, and buildings lends a new level of precision to RF planning for 5G mmWave networks that far surpasses the accuracy of conventional GIS data.
That means greater efficiency in the mmWave RF planning process. More accurate network planning takes the guesswork out of transmitter selection and placement. It also enables MNOs to cut costs by significantly reducing the number and length of physical site-surveys. With network design tasks taking just a few days, MNOs can more quickly perform upgrades, install new equipment, add capacity or respond to environment changes.
Michiel Verberg, Senior Manager, Strategic Partners, HERE Technologies,
said:
“The combined HERE, Infosys and Shields solution will enable
centralization and streamlining of many of the traditionally labor and
time-intensive tasks associated with 5G cell site selection via the 3D
digital site survey. It’s a cost-effective means to simplify 5G RF
engineering and network planning processes. This accelerates time to
service not only for MNOs but enterprises looking to build out 5G in
factories, ports and other sites. We are excited by the prospect of
continuing to collaborate with these talented partners as we design the
next generation of small cell mobile networks on behalf of our clients
all over the world.”
Gerrit van Dijken, Chief Technology Officer at Shields, said:
“I’m
very proud of what the team has achieved. I believe the solution solves
a number of problems for the RF planning process as the industry moves
into mmWave network roll-out and will be of great value to our operator
customers. I’m looking forward to the continued partnership with HERE
and Infosys to bring this solution to market.”
Nitesh Bansal, SVP and Global Head Engineering Services, Infosys, said:
“With
our focus on helping accelerate 5G network deployment, Infosys and our
partners – HERE Technologies and Shields – are introducing new services
for 5G radio frequency planning. Infosys is continuously working to
build and innovate new solutions to reduce time to market for 5G
wireless introduction and make it ‘ready to use’ for enterprises
everywhere.”
About Infosys Ltd
Infosys is a global leader in technology
services and consulting headquartered in India,
enabling clients in 45 countries to create and execute strategies for
their digital transformation. From engineering to application
development, knowledge management and business process management,
Infosys helps clients find the right problems to solve, and to solve
them effectively. A team of 200,000 innovators across the globe bring
their imagination, knowledge and experience across industries and
technologies to every project they undertake. For media enquiries,
please contact Infosys’s public relations team at: PR_Global@infosys.com
About Shields
Shields is a privately-owned company founded
in 1979 with regional headquarters in the U.K. and North America,
dedicated to improving telecom operator networks through the use of
innovation, quality, value and unparalleled service. Shields supports
telecom operators with their equipment infrastructure and
technical/on-site services' needs. For more information, please visit https://www.shields-e.com
About HERE Technologies
HERE, the Open Location Platform
company, enables people, enterprises and cities to harness the power of
location. By making sense of the world through the lens of location, we
empower our customers to achieve better outcomes – from helping a city
manage its infrastructure or an enterprise optimize its assets to
guiding driver to their destinations safely. To learn more about HERE,
including our new generation of cloud-based platform services, visit: http://360.here.com
and www.here.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190226005601/en/
Contact information
Infosys
PR_Global@infosys.com
Shields
Connor
O’Reilly
+1 810 348 5485
Connor.oreilly@shields-e.com
HERE
Technologies
Jordan Stark
+1 312 316 4537
jordan.stark@here.com
Dr.
Sebastian Kurme
+49 173 515 3549
sebastian.kurme@here.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse ® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 09:58:00 EEST | Press release
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause of disability and death. AD develops over many years, long before symptoms are evident, but the lack of accessible, minimally invasive diagnostics results in many patients remaining undiagnosed until the disease is well advanced, when few effective interventions remain. The Lumipulse G pT
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes17.5.2025 00:17:00 EEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 16:00:00 EEST | Press release
Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy and accessibility to even more consumers. Amazon customers will now be able to discover and purchase Or
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 13:47:00 EEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 13:30:00 EEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom